All Stories

  1. Genetic Screening of Patients With Inherited Fanconi Syndrome

    Article • Kidney International Reports, July 2026, Elsevier

    Professor Hiroshi Tanaka

  2. Retinoic Acid-inducible Gene-I Increases Interferon-stimulated Gene 15 Expression in Human Renal Proximal Tubule Epithelial Cells

    Article • In Vivo, April 2026, International Institute of Anticancer Research

    Professor Hiroshi Tanaka

  3. Recurrent C3 glomerulopathy after prolonged remission

    Article • Pediatric Nephrology, March 2026, Springer Science + Business Media

    Professor Hiroshi Tanaka

  4. Toll‐Like Receptor 3 Activation in Lupus Nephritis: A Renal Signature Supporting “Pseudoviral” Immunity

    Article • International Journal of Rheumatic Diseases, January 2026, Wiley

    Professor Hiroshi Tanaka

  5. Unveiling long-standing low-molecular-weight proteinuria: A proximal tubular mitochondrial enzyme impairment caused by EHHADH mutation

    Article • Pediatric Nephrology, October 2025, Springer Science + Business Media

    Professor Hiroshi Tanaka

  6. Tripartite motif 22 (TRIM22) downregulates TLR3-induced CCL5 expression in human renal proximal tubular epithelial cells

    Article • Molecular Biology Reports, March 2025, Springer Science + Business Media

    Professor Hiroshi Tanaka

  7. Long‐term outcome of tacrolimus‐based immunosuppressive treatment for patients with paediatric‐onset lupus nephritis

    Article • Nephrology, October 2024, Wiley

    Professor Hiroshi Tanaka

  8. Recovery from rituximab-associated persistent hypogammaglobulinaemia in children with nephrotic syndrome

    Article • Nephrology Dialysis Transplantation, October 2024, Oxford University Press (OUP)

    Professor Hiroshi Tanaka

  9. Cylindromatosis lysine 63 deubiquitinase (CYLD) suppress TLR3-mediated CCL5 expression in human renal proximal tubular epithelial cells

    Article • Molecular Biology Reports, September 2024, Springer Science + Business Media

    Professor Hiroshi Tanaka

  10. Interferon‐stimulated gene 56 positively regulates Toll‐like receptor 3‐mediated CXCL10 expression in human renal proximal tubular epithelial cells

    Article • FEBS Open Bio, June 2024, Wiley

    Professor Hiroshi Tanaka

  11. Early add-on use of belimumab as induction therapy for patients with childhood-onset systemic lupus erythematosus

    Article • Lupus, March 2024, SAGE Publications

    Professor Hiroshi Tanaka

  12. Clinical Characteristics of Cryopyrin‐Associated Periodic Syndrome and Long‐Term Real‐World Efficacy and Tolerability of Canakinumab in Japan: Results of a Nationwide Survey

    Article • Arthritis & Rheumatology, March 2024, Wiley

    Professor Hiroshi Tanaka

  13. Be aware of severe juvenile chronic iridocyclitis without evidence of arthritis: Juvenile chronic iridocyclitis revisited

    Article • International Journal of Rheumatic Diseases, September 2023, Wiley

    Professor Hiroshi Tanaka

  14. Expression of interferon-stimulated gene 20 (ISG20), an antiviral effector protein, in glomerular endothelial cells: possible involvement of ISG20 in lupus nephritis

    Article • Renal Failure, June 2023, Taylor & Francis

    Professor Hiroshi Tanaka

  15. Long-term outcome of tacrolimus monotherapy in a patient with lupus nephritis: A 12-year observation

    Article • Lupus, June 2023, SAGE Publications

    Professor Hiroshi Tanaka

  16. Glomerular endothelial expression of type I IFN-stimulated gene, DExD/H-Box helicase 60 via toll-like receptor 3 signaling: possible involvement in the pathogenesis of lupus nephritis

    Article • Renal Failure, April 2022, Taylor & Francis

    Professor Hiroshi Tanaka

  17. Underrecognized Frasier syndrome revisited: Paradoxical immunocomplex deposition

    Article • Pediatrics International, January 2022, Wiley

    Professor Hiroshi Tanaka

  18. Be aware of underlying Dent disease in young boys with massive proteinuria

    Article • Pediatrics International, January 2022, Wiley

    Professor Hiroshi Tanaka

  19. Interleukin-6 via Toll-Like Receptor 3 Signaling Attenuates the Expression of Proinflammatory Chemokines in Human Podocytes

    Article • Kidney and Blood Pressure Research, January 2021, Karger Publishers

    Professor Hiroshi Tanaka

  20. Inhibitory effect of anti-malarial agents on the expression of proinflammatory chemokines via Toll-like receptor 3 signaling in human glomerular endothelial cells

    Article • Renal Failure, January 2021, Taylor & Francis

    Professor Hiroshi Tanaka

  21. Podocyte sphingomyelin phosphodiesterase acid-like 3b decreases among children with idiopathic nephrotic syndrome

    Article • Clinical and Experimental Nephrology, September 2020, Springer Science + Business Media

    Professor Hiroshi Tanaka

  22. Orthostatic proteinuria revisited: new clinical impact of the “old” clinical entity?

    Article • Annals of Translational Medicine, July 2020, AME Publishing Company

    Professor Hiroshi Tanaka

  23. Interferon-induced transmembrane protein 1 and Myxovirus resistance protein 1 are induced by polyinosinic-polycytidylic acid in cultured hCMEC/D3 human cerebral microvascular endothelial cells

    Article • Journal of Neuroimmunology, December 2019, Elsevier

    Professor Hiroshi Tanaka

  24. Endothelial expression of fractalkine (CX3CL1) is induced by Toll-like receptor 3 signaling in cultured human glomerular endothelial cells

    Article • Modern Rheumatology, November 2019, Taylor & Francis

    Professor Hiroshi Tanaka

  25. Complete clinical resolution of a Japanese family with renal pseudohypoaldosteronism type 1 due to a novel NR3C2 mutation

    Article • Nephrology, March 2019, Wiley

    Professor Hiroshi Tanaka

  26. High prevalence of underlying orthostatic proteinuria in young Japanese women

    Article • Pediatrics International, March 2019, Wiley

    Professor Hiroshi Tanaka

  27. Induction of C‐C motif chemokine ligand 2 through Toll‐like receptor 3 signaling in human cerebral microvascular endothelial cell/D3 cells: possible regulation by nuclear factor‐κB

    Article • Clinical and Experimental Neuroimmunology, February 2019, Wiley

    Professor Hiroshi Tanaka

  28. Fatal case of Hajdu-Cheney syndrome with idiopathic pulmonary hemosiderosis

    Article • Pediatrics International, February 2019, Wiley

    Professor Hiroshi Tanaka

  29. Cytosolic Sensors of Viral RNA Are Involved in the Production of Interleukin-6 via Toll-Like Receptor 3 Signaling in Human Glomerular Endothelial Cells

    Article • Kidney and Blood Pressure Research, January 2019, Karger Publishers

    Professor Hiroshi Tanaka

  30. Overweight Children at a Primary School in Hirosaki City: A Longitudinal, Individualized, Observational Study

    Article • The Tohoku Journal of Experimental Medicine, January 2019, Tohoku University Medical Press

    Professor Hiroshi Tanaka

  31. Interferon-stimulated gene 60 (ISG60) constitutes a negative feedback loop in the downstream of TLR3 signaling in hCMEC/D3 cells

    Article • Journal of Neuroimmunology, November 2018, Elsevier

    Professor Hiroshi Tanaka

  32. Chloroquine attenuates TLR3-mediated plasminogen activator inhibitor-1 expression in cultured human glomerular endothelial cells

    Article • Clinical and Experimental Nephrology, October 2018, Springer Science + Business Media

    Professor Hiroshi Tanaka

  33. <b>Gnetin C suppresses double-stranded RNA-induced C-C motif chemokine ligand 2 (CCL2) and CCL5 production by inhibiting Toll-like receptor 3 signaling </b><b>pathway </b>

    Article • Biomedical Research, October 2018, Biomedical Research Press

    Professor Hiroshi Tanaka

  34. Long-term clinicopathologic observation in a case of steroid-resistant nephrotic syndrome caused by a novel Crumbs homolog 2 mutation

    Article • Nephrology, July 2018, Wiley

    Professor Hiroshi Tanaka, Kensuke Joh

  35. <b>Gnetin C, a resveratrol dimer, reduces amyloid-β 1–42 (Aβ42) production and ameliorates Aβ42-lowered cell viability in cultured SH-SY5Y human neuroblastoma </b><b>cells </b>

    Article • Biomedical Research, June 2018, Biomedical Research Press

    Professor Hiroshi Tanaka

  36. Retinoic acid-inducible gene-I, melanoma differentiation-associated gene 5 and C-X-C motif chemokine ligand 10 are induced by a Toll-like receptor 3 agonist in human brain microvascular endothelial cells

    Article • Clinical and Experimental Neuroimmunology, May 2018, Wiley

    Professor Hiroshi Tanaka

  37. Toll-Like Receptor 3 Signaling Contributes to Regional Neutrophil Recruitment in Cultured Human Glomerular Endothelial Cells

    Article • January 2018, Karger Publishers

    Professor Hiroshi Tanaka

  38. Free light chain-associated Fanconi syndrome in an adolescent

    Article • Pediatrics International, December 2017, Wiley

    Professor Hiroshi Tanaka

  39. Rebamipide reduces amyloid-β 1–42 (Aβ42) production and ameliorates Aβ43-lowered cell viability in cultured SH-SY5Y human neuroblastoma cells

    Article • Neuroscience Research, November 2017, Elsevier

    Professor Hiroshi Tanaka

  40. Urinary excretion of sphingomyelinase phosphodiesterase acid-like 3b in children with intractable nephrotic syndrome

    Article • Pediatrics International, October 2017, Wiley

    Professor Hiroshi Tanaka

  41. Expression of CCL5 is induced by polyinosinic : polycytidylic acid in cultured hCMEC/D3 human brain microvascular endothelial cells

    Article • Clinical and Experimental Neuroimmunology, September 2017, Wiley

    Professor Hiroshi Tanaka

  42. Treatment of pediatric-onset lupus nephritis: a proposal of optimal therapy

    Article • Clinical and Experimental Nephrology, March 2017, Springer Science + Business Media

    Professor Hiroshi Tanaka

  43. Interferon (IFN)-induced protein 35 (IFI35) negatively regulates IFN-β-phosphorylated STAT1-RIG-I-CXCL10/CCL5 axis in U373MG astrocytoma cells treated with polyinosinic-polycytidylic acid

    Article • Brain Research, March 2017, Elsevier

    Professor Hiroshi Tanaka

  44. Post-acute ischemic change and colon stricture in hemolytic uremic syndrome

    Article • Pediatrics International, February 2017, Wiley

    Professor Hiroshi Tanaka

  45. Chloroquine attenuates TLR3/IFN-β signaling in cultured normal human mesangial cells: A possible protective effect against renal damage in lupus nephritis

    Article • Modern Rheumatology, February 2017, Taylor & Francis

    Professor Hiroshi Tanaka

  46. Cylindromatosis (CYLD), a Deubiquitinase, Attenuates Inflammatory Signaling Pathways by Activating Toll-Like Receptor 3 in Human Mesangial Cells

    Article • Kidney and Blood Pressure Research, January 2017, Karger Publishers

    Professor Hiroshi Tanaka

  47. <b>DEC1 negatively regulates the expression of CXCL10 and CCL5 induced by poly IC in normal human mesangial </b><b>cells </b>

    Article • Biomedical Research, January 2017, Biomedical Research Press

    Professor Hiroshi Tanaka

  48. Clarithromycin attenuates the expression of monocyte chemoattractant protein-1 by activating toll-like receptor 4 in human mesangial cells

    Article • Clinical and Experimental Nephrology, September 2016, Springer Science + Business Media

    Professor Hiroshi Tanaka

  49. Hyper-IgE syndrome with a novel mutation of the STAT3 gene

    Article • Clinical and Experimental Dermatology, June 2016, Wiley

    Dr Satoko Minakawa, Professor Hiroshi Tanaka

  50. Does Dent disease remain an underrecognized cause for young boys with focal glomerulosclerosis?

    Article • Pediatrics International, June 2016, Wiley

    Professor Hiroshi Tanaka

  51. Monitoring of Epstein–Barr virus load and killer T cells in patients with juvenile idiopathic arthritis treated with methotrexate or tocilizumab

    Article • Modern Rheumatology, May 2016, Oxford University Press (OUP)

    Professor Hiroshi Tanaka

  52. Interferon-stimulated gene (ISG) 60, as well as ISG56 and ISG54, positively regulates TLR3/IFN-β/STAT1 axis in U373MG human astrocytoma cells

    Article • Neuroscience Research, April 2016, Elsevier

    Professor Hiroshi Tanaka

  53. Interferon (IFN)-Induced Protein 35 (IFI35), a Type I Interferon-Dependent Transcript, Upregulates Inflammatory Signaling Pathways by Activating Toll-Like Receptor 3 in Human Mesangial Cells

    Article • Kidney and Blood Pressure Research, January 2016, Karger Publishers

    Professor Hiroshi Tanaka

  54. Interferon-Stimulated Gene 15, a Type I Interferon-Dependent Transcript, Is Involved in a Negative Feedback Loop in Innate Immune Reactions in Human Mesangial Cells

    Article • January 2016, Karger Publishers

    Professor Hiroshi Tanaka

  55. Expressions of mRNA for innate immunity-associated functional molecules in urinary sediment in immunoglobulin A nephropathy

    Article • Nephrology, October 2015, Wiley

    Professor Hiroshi Tanaka

  56. Carnosic acid attenuates apoptosis induced by amyloid-β 1–42 or 1–43 in SH-SY5Y human neuroblastoma cells

    Article • Neuroscience Research, May 2015, Elsevier

    Professor Hiroshi Tanaka

  57. Desferrioxamine, an iron chelator, inhibits CXCL10 expression induced by polyinosinic–polycytidylic acid in U373MG human astrocytoma cells

    Article • Neuroscience Research, May 2015, Elsevier

    Professor Hiroshi Tanaka, Ken Furudate

  58. Alteration in the podoplanin–ezrin–cytoskeleton linkage is an important initiation event of the podocyte injury in puromycin aminonucleoside nephropathy, a mimic of minimal change nephrotic syndrome

    Article • Cell and Tissue Research, April 2015, Springer Science + Business Media

    Professor Hiroshi Tanaka

  59. Severe intrinsic acute kidney injury associated with therapeutic doses of acetaminophen

    Article • Pediatrics International, April 2015, Wiley

    Professor Hiroshi Tanaka

  60. Mizoribine in the treatment of pediatric-onset glomerular disease

    Article • World Journal of Pediatrics, March 2015, Springer Science + Business Media

    Professor Hiroshi Tanaka

  61. Toll-like receptor 3 signaling contributes to the expression of a neutrophil chemoattractant, CXCL1 in human mesangial cells

    Article • Clinical and Experimental Nephrology, December 2014, Springer Science + Business Media

    Professor Hiroshi Tanaka

  62. ISG54 and ISG56 are induced by TLR3 signaling in U373MG human astrocytoma cells: Possible involvement in CXCL10 expression

    Article • Neuroscience Research, July 2014, Elsevier

    Professor Hiroshi Tanaka

  63. Efficacy of mizoribine-tacrolimus-based induction therapy for pediatric lupus nephritis

    Article • Lupus, March 2014, SAGE Publications

    Professor Hiroshi Tanaka

  64. Tumor necrosis factor-α synergistically enhances polyinosinic-polycytidylic acid-induced toll-like receptor 3 signaling in cultured normal human mesangial cells: possible involvement in the pathogenesis of lupus nephritis

    Article • Clinical and Experimental Nephrology, March 2014, Springer Science + Business Media

    Professor Hiroshi Tanaka

  65. Carnosic acid suppresses the production of amyloid-β 1-42 and 1-43 by inducing an α-secretase TACE/ADAM17 in U373MG human astrocytoma cells

    Article • Neuroscience Research, February 2014, Elsevier

    Professor Hiroshi Tanaka

  66. Efficacy of long-term multidrug therapy in a patient with focal segmental glomerulosclerosis

    Article • Pediatrics International, February 2014, Wiley

    Professor Hiroshi Tanaka

  67. Mizoribine selectively attenuates monocyte chemoattractant protein-1 production in cultured human glomerular mesangial cell: A possible benefit of its use in the treatment of lupus nephritis

    Article • Nephrology, December 2013, Wiley

    Professor Hiroshi Tanaka

  68. Glomerular expression of myxovirus resistance protein 1 in human mesangial cells: Possible activation of innate immunity in the pathogenesis of lupus nephritis

    Article • Nephrology, November 2013, Wiley

    Professor Hiroshi Tanaka

  69. Single dose of rituximab for pediatric-onset refractory systemic lupus erythematosus

    Article • Lupus, August 2013, SAGE Publications

    Professor Hiroshi Tanaka

  70. Severe post-streptococcal acute glomerulonephritis and periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis syndrome

    Article • Pediatrics International, April 2013, Wiley

    Professor Hiroshi Tanaka

  71. Long-Term Tacrolimus-Based Immunosuppressive Treatment for Young Patients with Lupus Nephritis: A Prospective Study in Daily Clinical Practice

    Article • Nephron Clinical Practice, January 2013, Karger Publishers

    Professor Hiroshi Tanaka

  72. Inflammatory Chemokine Expression via Toll-Like Receptor 3 Signaling in Normal Human Mesangial Cells

    Article • Clinical and Developmental Immunology, January 2013, Hindawi Publishing Corporation

    Professor Hiroshi Tanaka

  73. Interaction between Interferon-Stimulated Gene 56 and Melanoma Differentiation-Associated Gene 5 in Toll-Like Receptor 3 Signaling in Normal Human Mesangial Cells

    Article • American Journal of Nephrology, January 2013, Karger Publishers

    Professor Hiroshi Tanaka

  74. TLR4 signaling induces retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5 in mesangial cells

    Article • Journal of Nephrology, January 2013, SAGE Publications

    Professor Hiroshi Tanaka

  75. Urinary Fractalkine and Monocyte Chemoattractant Protein-1 as Possible Predictors of Disease Activity of Childhood Glomerulonephritis

    Article • The Tohoku Journal of Experimental Medicine, January 2013, Tohoku University Medical Press

    Professor Hiroshi Tanaka

  76. A young girl with refractory intestinal Behçet’s disease: a case report and review of literatures on pediatric cases who received an anti-tumor necrosis factor agent

    Article • Rheumatology International, December 2012, Springer Science + Business Media

    Professor Hiroshi Tanaka

  77. Persistent Immature Glomeruli in a Girl with Refractory Nephrotic Syndrome

    Article • Nephrology, December 2012, Wiley

    Professor Hiroshi Tanaka

  78. Glomerular expression of fractalkine is induced by polyinosinic-polycytidylic acid in human mesangial cells: possible involvement of fractalkine after viral infection

    Article • Pediatric Research, November 2012, Springer Science + Business Media

    Professor Hiroshi Tanaka

  79. Long-term multidrug therapy in an adolescent patient with proliferative lupus nephritis: a trial of less cytotoxic therapy

    Article • Clinical Nephrology, October 2012, Dustri-Verlgag Dr. Karl Feistle

    Professor Hiroshi Tanaka

  80. Treatment of young patients with lupus nephritis using calcineurin inhibitors

    Article • World Journal of Nephrology, January 2012, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Professor Hiroshi Tanaka

  81. Melanoma Differentiation-Associated Gene 5 Regulates the Expression of a Chemokine CXCL10 in Human Mesangial Cells: Implications for Chronic Inflammatory Renal Diseases

    Article • The Tohoku Journal of Experimental Medicine, January 2012, Tohoku University Medical Press

    Professor Hiroshi Tanaka

  82. Imbalance towards Th1 pathway predominance in purpura nephritis with proteinuria

    Article • Pediatric Nephrology, December 2011, Springer Science + Business Media

    Professor Hiroshi Tanaka

  83. Autoantibodies to villin occur frequently in IPEX, a severe immune dysregulation, syndrome caused by mutation of FOXP3

    Article • Clinical Immunology, October 2011, Elsevier

    Professor Hiroshi Tanaka

  84. Polyinosinic-Polycytidylic Acid Induces the Expression of Interferon-Stimulated Gene 20 in Mesangial Cells

    Article • Nephron Experimental Nephrology, August 2011, Karger Publishers

    Professor Hiroshi Tanaka

  85. Novel multidrug therapy for children with cyclosporine-resistant or -intolerant nephrotic syndrome

    Article • Pediatric Nephrology, August 2011, Springer Science + Business Media

    Professor Hiroshi Tanaka

  86. Tacrolimus monotherapy in a patient with lupus flare using once-daily administration protocol

    Article • Clinical Kidney Journal, July 2011, Oxford University Press (OUP)

    Professor Hiroshi Tanaka

  87. Basic-helix-loop-helix transcription factor DEC2 constitutes negative feedback loop in IFN-β-mediated inflammatory responses in human mesangial cells

    Article • Immunology Letters, April 2011, Elsevier

    Professor Hiroshi Tanaka

  88. Addition of mizoribine to the prednisolone plus tacrolimus treatment regimen in a patient with lupus flare

    Article • Rheumatology International, March 2011, Springer Science + Business Media

    Professor Hiroshi Tanaka

  89. Successful Multidrug Treatment of a Pediatric Patient with Severe Churg-Strauss Syndrome Refractory to Prednisolone

    Article • The Tohoku Journal of Experimental Medicine, January 2011, Tohoku University Medical Press

    Professor Hiroshi Tanaka

  90. Clinical responses to EGFR-tyrosine kinase inhibitor retreatment in non-small cell lung cancer patients who benefited from prior effective gefitinib therapy: a retrospective analysis

    Article • BMC Cancer, January 2011, Springer Science + Business Media

    Professor Hiroshi Tanaka

  91. Efficacy and safety of tacrolimus in 101 consecutive patients with rheumatoid arthritis: a possible alternative treatment to methotrexate?

    Article • International Journal of Clinical Rheumatology, October 2010, OMICS Publishing Group

    Professor Hiroshi Tanaka

  92. Retinoic acid-inducible gene-I is induced by double-stranded RNA and regulates the expression of CC chemokine ligand (CCL) 5 in human mesangial cells

    Article • Nephrology Dialysis Transplantation, May 2010, Oxford University Press (OUP)

    Professor Hiroshi Tanaka

  93. Mizoribine attenuates renal injury and macrophage infiltration in patients with severe lupus nephritis

    Article • Clinical Rheumatology, May 2010, Springer Science + Business Media

    Professor Hiroshi Tanaka

  94. Potential Th1/Th2 predominance in children with newly diagnosed IgA nephropathy

    Article • Acta Paediatrica, May 2010, Wiley

    Professor Hiroshi Tanaka

  95. Intravenous immunoglobulin therapy leading to dramatic improvement in a patient with systemic juvenile idiopathic arthritis and severe pericarditis resistant to steroid pulse therapy

    Article • Rheumatology International, March 2010, Springer Science + Business Media

    Professor Hiroshi Tanaka

  96. Retinoic acid-inducible gene-I (RIG-I) is induced by IFN-  in human mesangial cells in culture: possible involvement of RIG-I in the inflammation in lupus nephritis

    Article • Lupus, February 2010, SAGE Publications

    Professor Hiroshi Tanaka

  97. Benefits of Once-Daily Administration of Cyclosporine A for Children with Steroid-Dependent, Relapsing Nephrotic Syndrome

    Article • The Tohoku Journal of Experimental Medicine, January 2010, Tohoku University Medical Press

    Professor Hiroshi Tanaka

  98. IFN-γ and TNF-α Synergistically Induce microRNA-155 Which Regulates TAB2/IP-10 Expression in Human Mesangial Cells

    Article • American Journal of Nephrology, January 2010, Karger Publishers

    Professor Hiroshi Tanaka

  99. Use of recombinant human serum albumin in pediatric patients with nephrotic syndrome

    Article • Pediatric Nephrology, May 2009, Springer Science + Business Media

    Professor Hiroshi Tanaka

  100. A novel multidrug therapy for difficult cyclosporine-resistant focal segmental glomerulosclerosis

    Article • Pediatric Nephrology, April 2009, Springer Science + Business Media

    Professor Hiroshi Tanaka

  101. Mizoribine Treatment of Young Patients with Severe Lupus Nephritis: A Clinicopathologic Study by the Tohoku Pediatric Study Group

    Article • Nephron Clinical Practice, September 2008, Karger Publishers

    Professor Hiroshi Tanaka

  102. Vesical varices and telangiectasias in a patient with ataxia telangiectasia

    Article • Pediatric Nephrology, June 2008, Springer Science + Business Media

    Professor Hiroshi Tanaka

  103. Effective treatment of young patients with pediatric-onset, long-standing lupus nephritis with tacrolimus given as a single daily dose: an open-label pilot study

    Article • Lupus, November 2007, SAGE Publications

    Professor Hiroshi Tanaka

  104. Long-term intermittent pulse therapy with mizoribine attenuates histologic progression in young patients with severe lupus nephritis: Report of two patients (Brief Communication)

    Article • Nephrology, August 2007, Wiley

    Professor Hiroshi Tanaka

  105. Mizoribine intermittent pulse protocol for induction therapy for systemic lupus erythematosus in children: an open-label pilot study with five newly diagnosed patients

    Article • Clinical Rheumatology, May 2007, Springer Science + Business Media

    Professor Hiroshi Tanaka

  106. Treatment of difficult cases of systemic-onset juvenile idiopathic arthritis with tacrolimus

    Article • European Journal of Pediatrics, December 2006, Springer Science + Business Media

    Professor Hiroshi Tanaka

  107. Acute renal failure with encephalopathy following Salmonellaenteritidis infection

    Article • Pediatric Nephrology, August 2006, Springer Science + Business Media

    Professor Hiroshi Tanaka

  108. Long-term mizoribine intermittent pulse therapy for young patients with flare of lupus nephritis

    Article • Pediatric Nephrology, July 2006, Springer Science + Business Media

    Professor Hiroshi Tanaka

  109. Leukocytapheresis for the treatment of refractory systemic-onset juvenile idiopathic arthritis

    Article • Clinical Rheumatology, March 2006, Springer Science + Business Media

    Professor Hiroshi Tanaka

  110. Renal Biopsy Findings in Children Receiving Long-Term Treatment with Cyclosporine A Given as a Single Daily Dose

    Article • The Tohoku Journal of Experimental Medicine, January 2006, Tohoku University Medical Press

    Professor Hiroshi Tanaka

  111. Low-dose cyclosporine A in a patient with X-linked immune dysregulation, polyendocrinopathy and enteropathy

    Article • European Journal of Pediatrics, August 2005, Springer Science + Business Media

    Professor Hiroshi Tanaka

  112. Implication of the peak serum level of mizoribine for control of the serum anti-dsDNA antibody titer in patients with lupus nephritis

    Article • Clinical Nephrology, June 2005, Dustri-Verlgag Dr. Karl Feistle

    Professor Hiroshi Tanaka

  113. Single-dose daily administration of cyclosporin A for refractory nephrotic syndrome

    Article • Pediatric Nephrology, May 2005, Springer Science + Business Media

    Professor Hiroshi Tanaka

  114. Mizoribine Pulse Therapy for a Pediatric Patient with Steroid-Resistant Nephrotic Syndrome

    Article • The Tohoku Journal of Experimental Medicine, January 2005, Tohoku University Medical Press

    Professor Hiroshi Tanaka

  115. Mizoribine for the treatment of lupus nephritis in children and adolescents

    Article • Clinical Nephrology, December 2004, Dustri-Verlgag Dr. Karl Feistle

    Professor Hiroshi Tanaka

  116. Combined therapy of enalapril and losartan attenuates histologic progression in immunoglobulin A nephropathy

    Article • Pediatrics International, October 2004, Wiley

    Professor Hiroshi Tanaka

  117. Severe tubulointerstitial nephritis in a boy with refractory nephrotic syndrome

    Article • Pediatric Nephrology, August 2004, Springer Science + Business Media

    Professor Hiroshi Tanaka

  118. Single-dose daily administration of cyclosporin�A for relapsing nephrotic syndrome

    Article • Pediatric Nephrology, May 2004, Springer Science + Business Media

    Professor Hiroshi Tanaka

  119. Spontaneous remission of persistent severe hematuria in an adolescent with nutcracker syndrome: seven years? observation

    Article • Clinical and Experimental Nephrology, March 2004, Springer Science + Business Media

    Professor Hiroshi Tanaka

  120. Repeat renal biopsy in children with severe idiopathic tubulointerstitial nephritis

    Article • Pediatric Nephrology, February 2004, Springer Science + Business Media

    Professor Hiroshi Tanaka

  121. Effective Therapy of a Child Case of Refractory Nephrotic Syndrome with Tacrolimus

    Article • The Tohoku Journal of Experimental Medicine, January 2004, Tohoku University Medical Press

    Professor Hiroshi Tanaka

  122. Letter

    Article • Acta Paediatrica, January 2004, Wiley

    Professor Hiroshi Tanaka

  123. Mizoribine oral pulse therapy for patients with disease flare of lupus nephritis

    Article • Clinical Nephrology, December 2003, Dustri-Verlgag Dr. Karl Feistle

    Professor Hiroshi Tanaka

  124. Successful treatment with leukocytapheresis in refractory Henoch-Sch�nlein purpura: case report

    Article • Clinical Rheumatology, September 2003, Springer Science + Business Media

    Professor Hiroshi Tanaka

  125. Mizoribine oral pulse therapy for a patient with severe lupus nephritis

    Article • Pediatrics International, August 2003, Wiley

    Professor Hiroshi Tanaka

  126. Acute renal failure due to hypertension: Malignant hypertension in an adolescent

    Article • Pediatrics International, June 2003, Wiley

    Professor Hiroshi Tanaka

  127. End-Stage Kidney at the Onset of Nephrotic Syndrome in a 4-Year-Old Girl

    Article • The Tohoku Journal of Experimental Medicine, January 2003, Tohoku University Medical Press

    Professor Hiroshi Tanaka

  128. Childhood idiopathic membranous glomerulonephritis with isolated antinuclear antibody positivity

    Article • Clinical and Experimental Nephrology, December 2002, Springer Science + Business Media

    Professor Hiroshi Tanaka

  129. Disseminated candidiasis following prednisolone therapy in systemic lupus erythematosus

    Article • Pediatrics International, December 2002, Wiley

    Professor Hiroshi Tanaka

  130. Rapidly progressive, pauci-immune diffuse crescentic glomerulonephritis in an infant

    Article • Pediatric Nephrology, September 2002, Springer Science + Business Media

    Professor Hiroshi Tanaka

  131. Immunogenicity and Therapeutic Efficacy of Dendritic–Tumor Hybrid Cells Generated by Electrofusion

    Article • Clinical Immunology, July 2002, Elsevier

    Professor Hiroshi Tanaka

  132. Subsequent Progression to Membranous Glomerulonephritis Following Exacerbation of Urticarial Rash in Systemic Lupus Erythematosus: Report of 2 Cases.

    Article • The Tohoku Journal of Experimental Medicine, January 2002, Tohoku University Medical Press

    Professor Hiroshi Tanaka

  133. A Japanese Child with Senior-Loken Syndrome

    Article • Japanese Journal of Ophthalmology, December 2001, Elsevier

    Professor Hiroshi Tanaka

  134. Repeat renal biopsy in a girl with tubulointerstitial nephritis and uveitis syndrome

    Article • Pediatric Nephrology, November 2001, Springer Science + Business Media

    Professor Hiroshi Tanaka

  135. Methylprednisolone pulse therapy in Japanese children with severe lupus nephritis

    Article • Pediatric Nephrology, October 2001, Springer Science + Business Media

    Professor Hiroshi Tanaka

  136. Senior-Loken syndrome associated with mental retardation and microcephaly

    Article • Pediatrics International, June 2001, Wiley

    Professor Hiroshi Tanaka

  137. Acute renal failure at the onset of idiopathic nephrotic syndrome in two children

    Article • Clinical and Experimental Nephrology, April 2001, Springer Science + Business Media

    Professor Hiroshi Tanaka

  138. Thrombotic Stroke in a Child with Diarrhea-Associated Hemolytic-Uremic Syndrome with a Good Recovery.

    Article • The Tohoku Journal of Experimental Medicine, January 2001, Tohoku University Medical Press

    Professor Hiroshi Tanaka

  139. Tubulointerstitial Nephritis and Uveitis Syndrome in Two Siblings.

    Article • The Tohoku Journal of Experimental Medicine, January 2001, Tohoku University Medical Press

    Professor Hiroshi Tanaka

  140. Contribution of macromolecular IgA 1 to IgA abnormality in IgA nephropathy

    Article • Pediatric Nephrology, October 2000, Springer Science + Business Media

    Professor Hiroshi Tanaka

  141. Interstitial cystitis and ileus in pediatric-onset systemic lupus erythematosus

    Article • Pediatric Nephrology, July 2000, Springer Science + Business Media

    Professor Hiroshi Tanaka

  142. Allogeneic CD34-selected peripheral stem cell transplant for acute non-lymphocytic leukemia (FAB M5a) developed from juvenile chronic myelogenous leukemia

    Article • Pediatrics International, January 2000, Wiley

    Professor Hiroshi Tanaka

  143. A phase I dose escalation study of multicyclic, dose-intensive chemotherapy with peripheral blood stem cell support for small cell lung cancer

    Article • British Journal of Pharmacology, January 2000, Springer Science + Business Media

    Professor Hiroshi Tanaka

  144. Acute Glomerulonephritis Superimposed on Focal Segmental Glomerulosclerosis: A Case Report

    Article • The Tohoku Journal of Experimental Medicine, January 2000, Tohoku University Medical Press

    Professor Hiroshi Tanaka

  145. Complete Occulusion of Left Renal Artery in Pediatric-Onset Takayasu's Arteritis

    Article • The Tohoku Journal of Experimental Medicine, January 2000, Tohoku University Medical Press

    Professor Hiroshi Tanaka

  146. Focal Segmental Glomerulosclerosis: Unremitting Proteinuria of Long Duration as a Possible Etiology ?

    Article • The Tohoku Journal of Experimental Medicine, January 2000, Tohoku University Medical Press

    Professor Hiroshi Tanaka

  147. Distal type of renal tubular acidosis after anti-epileptic therapy in a girl with infantile spasms

    Article • Clinical and Experimental Nephrology, December 1999, Springer Science + Business Media

    Professor Hiroshi Tanaka

  148. Acute glomerulonephritis associated with pneumonia: A possible Chlamydia pneumoniae etiology?

    Article • Pediatrics International, December 1999, Wiley

    Professor Hiroshi Tanaka

  149. Glomerulonephritis without IgA deposits in a case of Henoch-Schönlein purpura

    Article • Pediatric Nephrology, August 1999, Springer Science + Business Media

    Professor Hiroshi Tanaka

  150. Acute Tubulointerstitial Nephritis Following Intravenous Immunoglobulin Therapy in a Male Infant with Minimal-Change Nephrotic Syndrome.

    Article • The Tohoku Journal of Experimental Medicine, January 1999, Tohoku University Medical Press

    Professor Hiroshi Tanaka

  151. Long-Term Azathioprine Therapy in Two Children with Steroid-Dependent Minimal-Change Nephrotic Syndrome.

    Article • The Tohoku Journal of Experimental Medicine, January 1999, Tohoku University Medical Press

    Professor Hiroshi Tanaka

  152. Subclinical Sjögren's syndrome: A significant67gallium accumulation in the orbits and parotid glands

    Article • Pediatrics International, December 1998, Wiley

    Professor Hiroshi Tanaka

  153. Trisomy 6 in a childhood acute mixed lineage leukemia

    Article • Pediatrics International, December 1998, Wiley

    Professor Hiroshi Tanaka

  154. An infant case of bilateral small kidneys with both proximal and distal tubular dysfunction

    Article • Pediatrics International, August 1998, Wiley

    Professor Hiroshi Tanaka

  155. Successful treatment of Wernicke's encephalopathy in a boy with acute mixed lineage leukemia

    Article • Pediatrics International, June 1998, Wiley

    Professor Hiroshi Tanaka

  156. Age-Related Histologic Alterations after Prednisolone Therapy in Children with IgA Nephropathy.

    Article • The Tohoku Journal of Experimental Medicine, January 1998, Tohoku University Medical Press

    Professor Hiroshi Tanaka

  157. Efficacy of Long-Term Sulfamethoxazole-Trimethoprim Therapy in a Boy with Hyperimmunoglobulin E Syndrome.

    Article • The Tohoku Journal of Experimental Medicine, January 1998, Tohoku University Medical Press

    Professor Hiroshi Tanaka

  158. Capacity of H2O2 Release from Monocytes in Steroid-Sensitive Nephrotic Sytndrome.

    Article • The Tohoku Journal of Experimental Medicine, January 1996, Tohoku University Medical Press

    Professor Hiroshi Tanaka

  159. Production of monocyte chemoattractant protein-1 by bovine glomerular endothelial cells

    Article • Kidney International, December 1995, Elsevier

    Professor Hiroshi Tanaka